Dr Chandran Kumar

Department: Hepatology and Lead Transplant Physician

Designation: Sr. Consultant - Hepatology and Lead Transplant Physician


Book an appointment

Dr K.N. Chandra Kumar is an experienced Hepatologist and Liver Transplant Physician. With an experience of 8 years, he is extremely proficient and skilled. His research work is impeccable with numerous papers and articles published in various national and international journals. In addition to this, Dr Chandra Kumar also has participated in many conferences and panel discussions to hone his knowledge and keep himself updated about the latest findings in his field.

He has been trained at reputed medical institutes and worked in many research institutes and hospitals. He is an esteemed professor who has worked as the assistant professor at Sri Ramachandra Institute of Higher Education and Research, Chennai and Institute of Liver and Biliary Sciences, New Delhi.                



  • August 2018 to July 2020

Assistant Professor, Department of Hepatology, Sri Ramachandra Institute of Higher Education and Research, Chennai

  • September 2014 to July 2018

Consultant Hepatologist and Liver Transplant Physician, Institute of Liver Disease and  Transplantation, Gleneagles Global Health City, Chennai

  • July 2013 to August 2014

Assistant Professor, Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi


  • Kedarisetty CK, Kumar A. Sarin SK.Insights into Role of Granulocyte stimulating factor in severe alcoholic hepatitis. Seminar in Liver Disease 2020 ; accepted for publication 
  • Kedarisetty CK, Jain M, Selvan TS et al. Bacterial and parasitic infections of the liver. Oxford University Press 2020
  • Kedarisetty CK, Bal S,Parida S et al. Role of N-acetyl cysteine in post TACE transaminitis in hepatocellular carcinoma- a single centre experience J.Clin Exp Hepatol 2020; in peer review
  • Kedarisetty CK, Bhardwaj A, Kumar G et al. Efficacy of a combination of Pentoxifylline and Vitamin E versus Vitamin E alone in Non-alcoholic Steatohepatitis-A randomized controlled trial. J Gastroenterol Hepatol 2020; in peer review
  • Kedarisetty CK, Samaga B L, Vidyasagar S, Venkataraman J.Oral Melatonin improves the detection of parasitemia in malaria. J.Infect Dev Ctries 2020; accepted for publication
  • Kedarisetty CK, Bhargav V, Karthikeyan M et al. ‘’Wilson’s disease presenting as ACLF: A mystery yet to be solved . J Clin Exp Hepatol 2020; doi.org/10.1016j.jech.2020.04.013
  • Kedarisetty CK, Senthil Kumar MP, Bhargav V et al. Understanding the Basic Concepts of Liver Transplantation. Acta Scientific Gastro Dis 2020;3(2):1-9
  • Jain M, Kedarisetty CK, Selevan TS, Senthil Kumar MP, Venkataraman J. Does Gender matter in Liver Transplantation. Clinical Apporach and Management Strategies of Medical Ailment in Women; Oorja – The Power of Her 2020
  • Varadharajan J, Kedarisetty CK et al, Acute Kidney Injury in a Patient treated with Tenofovir Alafenamide Fumarate for Hepatitis B Virus Infection. Saudi J Kidney Dis Transpl 2020;  accepted for publication
  • Kedarisetty CK, Sridhar A, Durairaj S et al. Predictors of abnormal and setting of normal values of AST and ALT for Indian population. J Gastroenterol Hepatol 2019;  doi.org/10.1111/jgh.14865 
  • Kedarisetty CK, Bhargav V, Karthikeyan M et al. The predicament of the PREDICT study. J Clin Exp Hepatol 2019, DOI:10.1016/j.jceh.2019.11.007
  • Kedarisetty CK, Katukuri GR, Venkataraman J. Saline irrigation for residual CBD stones. Is it indicated for all? American J Gastroenterol 2019; 114 (3): 536, DOI: 10.14309/ajg.0000000000000094
  • Kedarisetty CK, Kamble R, Joseph S, Venkataraman J.Management of Hepatopulmonary syndrome in a child due to a Large Congenital Intrahepatic Porto-Systemic shunt.  International J Gastroenterology 2019; 3(1) :23-26. Doi :10.11648/j.ijg.20190301.14
  • Devarbhavi H, Choudhary A, Kedarisetty CK et al. Drug induced Acute-on-chronic liver failure in Asian patients : America J Gastroenterol 2019;114(6) : 929-937
  • Bokarvadia R.Jain M, Kedarisetty CK et al. Prevalence and clinical presentation of cirrhotic cardiomyopathy : A single center experience from southern India.Indian J Gasteroenterol  2019;38(2) : 150-157
  • Sanglodkar U, Jain M, Kedarisetty CK, Varghese J,Venkataraman J. Clinical audit to determine the efficacy of daily infusion of low dose 20% albumin in combination with  antibiotics in patients with spontaneous bacterial peritonitis Clin Exp Hepatol 2019;5(4):301- 307 
  • Anand L, Bihari C, Kedarisetty CK,Rooge SB et al. Early cirrhosis and a preserved bone marrow niche favor regenerative response to growth factors in decompensated cirrhosis.  Liver International 2018; doi : 10.1111/Iiv.13923
  • Bhadoria AS, Kedarisetty CK, Bhardwaj A et al. Positive family history for metabolic traits predisposes to early and more severe alcoholic : A cross-sectional study. Liver International  2018;doi:10.1111/Iiv.13958 
  • Bhadoria AS, Kedarisetty CK, Bihari C, Kumar G et al. Impact of family history of metabolic traits on severity of NASH related cirrhosis : a cross-sectional study. Liver International 2017;doi:10.1111/Iiv.13396
  • Varghese J,Kedarisetty CK, Venkataraman J, Srinivasan V et al. Combination of TACE and sorafenib improves outcomes in BCLC stages B/C of Hepatocellular carcinoma : A single  center experience. Annals of Hepatology 2017;16(2):247-254
  • Choudhary A, Kedarisetty CK, Vashishtha C et al. A randomised trial comparing terlipressin and noradrenaline in patients with septic shock. Liver International 2017;37(4):552-561
  • Maiwall R, Sarin SK, Kumar S, Kedarisetty CK, Abbas Z et al. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liiver failure. Liver International 2017;doi:10.1111/Iiv.13443
  • Jain M, Varghese J, Kedarisetty CK, Balajee G et al. An insight into antibiotic resistance to bacterial infection in chronic liver disease. J Clin Exp Hepatol 2017;7(4): 305-309

Back to Our Doctors